News
Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...
Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...
MIT developed an adhesive inspired by remoras that sticks to wet tissues, aiding drug delivery and monitoring.
In modern functional genomics, understanding how specific genes control cellular behavior requires both targeted intervention and high-resolution analysis. That''s where Perturb-Seq comes in-a method ...
We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...
6h
InvestorsHub on MSNAvidity Biosciences shares climb after FDA grants Breakthrough Therapy designationShares of Avidity Biosciences, Inc. (NASDAQ:RNA) rose 4% Wednesday following the announcement that its drug candidate, delpacibart zotadirsen (del-zota), has been awarded Breakthrough Therapy status ...
Inspired by a hitchhiking fish that uses a specialized suction organ to latch onto sharks and other marine animals, ...
Scientists have decoded the Swiss genome of the 1918 flu virus from a century-old specimen, revealing early adaptations for ...
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve ...
In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously "undruggable" cancer-driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results